Residual fluid after anti-VEGF therapy for AMD may not be tolerable or beneficial

• Posted on: May 5 2023
• By: Saratoga Opthalmology
• Leave a response

The absence of retinal fluid after anti-VEGF treatment for neovascular age-related macular degeneration (AMD) correlated with better outcomes in this 2-year post hoc study.
Source: AAO

Posted in: Uncategorized